Description

Family Planning with MS

Multiple sclerosis affects young adults in their thirties and more women than men are affected. During this period, family planning is an important topic for many people with MS. The disease is basically not inherited and people with MS should not be discouraged to become parents.

In this presentation the main interactions between MS and pregnancy and vice versa will be covered. Current data on exposed pregnancies on disease modifying treatments and how to proceed with the medication before, during or after pregnancy will be presented. Women with MS can be supported to breastfed, a topic which also will be addressed in this presentation.

Details

Date:  30 January 2020

Time: 19:30

Venue: Zoom

Cost: Free

Requirements

 

1) Device: Laptop, tablet or mobile phone

2) Internet connection

3) Zoom

Speakers

Prof Kerstin Hellwig

Senior Consultant in the Department of Neurology @ St. Josef Hospital / Ruhr University, Bochum, Germany

 

Dr. Hellwig attended medical schools at the Ruhr University, Germany, the Louis Pasteur University, France and the University of Stellenbosch, South Africa.  She became a board-certified neurologist after her residency at the St. Josef Hospital Bochum, Ruhr University Bochum. Dr. Hellwig holds a postdoctoral lecture qualification in “Special therapeutic aspects in patients with multiple sclerosis”.  With a grant from the German Research Foundation (DFG) Dr. Hellwig worked on a MS susceptibility research project at the research department of Kaiser Permanente in Pasadena, California and was trained in epidemiology and clinical research in department of Preventive Medicine of the University of Southern California (USC).


Her scientific interest is mainly clinical with a special interest in the field of MS and family planning. Since 2006, she has initiated and maintained the German-speaking MS and pregnancy registry (DMSKW). She published multiple peer-reviewed manuscripts.

Disclaimer and Policies: Learn more about our site, how we use your information, and using our content.

Privacy Policy: Rare Diseases South Africa (RDSA) respects your privacy and is committed to protect the personal information that you share with us. Our database contains private information including name, address, contact information and medical information. If you provide any private or non-public information it will be restricted to site administrators and individuals on a need-to-know basis and will not be sold or given outside of RDSA without consent from you. 

Disclaimer: Rare Disease South Africa (RDSA) is a resource for sharing information and support. RDSA members, employees and executive board members do not offer medical advice. The information provided on the RDSA website, newsletter and message board are designed to support, not replace, the relationship that exists between a patient/RDSA member and his/her physician. Please verify any information you receive from RDSA with other sources and with your licensed health care provider. Decisions regarding medical care should be made with your healthcare provider. Consumers should never disregard or delay seeking medical advice due to the content of this website. The RDSA executive and medical boards, volunteers and moderators do not assume, and hereby disclaims, any and all liability to any person or entity for any claims, damages, liability or other loss including, without limitation, any liability for injury or other damage resulting from any use of, or reliance on, this service or from the posting of any content or material by any third party.

© Rare Diseases South Africa